Veliz, E.A.; Kaplina, A.; Hettiarachchi, S.D.; Yoham, A.L.; Matta, C.; Safar, S.; Sankaran, M.; Abadi, E.L.; Cilingir, E.K.; Vallejo, F.A.;
et al. Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier. Pharmaceutics 2022, 14, 1465.
https://doi.org/10.3390/pharmaceutics14071465
AMA Style
Veliz EA, Kaplina A, Hettiarachchi SD, Yoham AL, Matta C, Safar S, Sankaran M, Abadi EL, Cilingir EK, Vallejo FA,
et al. Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier. Pharmaceutics. 2022; 14(7):1465.
https://doi.org/10.3390/pharmaceutics14071465
Chicago/Turabian Style
Veliz, Eduardo A., Anastasiia Kaplina, Sajini D. Hettiarachchi, Athina L. Yoham, Carolina Matta, Sabrin Safar, Meghana Sankaran, Esther L. Abadi, Emel Kirbas Cilingir, Frederic A. Vallejo,
and et al. 2022. "Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier" Pharmaceutics 14, no. 7: 1465.
https://doi.org/10.3390/pharmaceutics14071465
APA Style
Veliz, E. A., Kaplina, A., Hettiarachchi, S. D., Yoham, A. L., Matta, C., Safar, S., Sankaran, M., Abadi, E. L., Cilingir, E. K., Vallejo, F. A., Walters, W. M., Vanni, S., Leblanc, R. M., & Graham, R. M.
(2022). Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier. Pharmaceutics, 14(7), 1465.
https://doi.org/10.3390/pharmaceutics14071465
